Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q3 2016 · 10-Q
Revenue$1.41M$1.41M+55.6% vs Q3 2015 Net Income$181.49K$181.49KN/M vs Q3 2015 EPS Diluted$0.00$0.00— vs Q3 2015 Gross Profit$1,197,891+69.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flowderived$272,490N/M Free Cash Flowderived$270,164N/M Margins · derivedGross margin85.0%+6.8 pt vs Q3 2015
Operating margin15.3%+29.9 pt vs Q3 2015
Net margin12.9%+32.6 pt vs Q3 2015
ended Sep 30, 2016 · filed Nov 10, 2016 · 41 d after period end